Skip to main content
. Author manuscript; available in PMC: 2017 Aug 14.
Published in final edited form as: Ann Surg Oncol. 2016 Nov 2;24(4):952–959. doi: 10.1245/s10434-016-5646-9

FIG. 3.

FIG. 3

Melanoma-specific survival among sentinel lymph node (SLN)-positive patients compared with clinical nodal recurrence (CNR) at John Wayne Cancer Institute (JWCI) and Pennsylvania’s Pigmented Lesion Group (Penn). The SLN-positive patients at JWCI (solid red) and Penn (dashed red). The CNR patients at JWCI (solid blue) and Penn (dashed blue)